Page last updated: 2024-10-25

ciprofibrate and Hyperplasia

ciprofibrate has been researched along with Hyperplasia in 2 studies

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research Excerpts

ExcerptRelevanceReference
"The peroxisome proliferator ciprofibrate induces hypergastrinemia and as a consequence, enterochromaffin-like (ECL) cell hyperplasia."3.70Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia. ( Bakke, I; Sandvik, AK; Waldum, HL, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, ZY1
Liu, YF1
He, CY1
White, CC1
Eaton, DL1
Bakke, I1
Sandvik, AK1
Waldum, HL1

Other Studies

2 other studies available for ciprofibrate and Hyperplasia

ArticleYear
Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules.
    Cancer research, 1994, May-15, Volume: 54, Issue:10

    Topics: Animals; Cell Division; Clofibric Acid; Cytochrome P-450 Enzyme System; DNA; Fibric Acids; gamma-Glu

1994
Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia.
    Journal of molecular endocrinology, 2000, Volume: 25, Issue:1

    Topics: Animals; Chromogranin A; Chromogranins; Clofibric Acid; Enterochromaffin Cells; Female; Fibric Acids

2000